Stem Cell Therapy for Blindness

Stem Cell Therapy for Blindness

Pfizer in collaboration with University College London (UCL) has developed PF 5206388, an intraocular implant consisting of a single layer of retinal pigment epithelium (RPE) cells. It consists of a polymer framework carrying stem cells, designed to be set into the eye, according to Biotecnika on August 2, 2017.

This therapy first treated a patient in 2015, however, Pfizer has recently updated the therapy. It has abandoned four of its early-stage clinical projects, including the stem cell therapy. Pfizer derived cells from the embryonic stem cells and designed them for patients with a disorder that causes blindness.

In a clinical trial conducted by the specialists at Moorfields Eye Hospital, 10 patients were to be treated of a disease called wet age-related macular degeneration (AMD). Surgeons inserted a specially engineered patch behind the retina of the patients to deliver the stem cells. The operation was successful on all the 10 participants.

PF-06282999 was created for treating acute coronary syndrome (ACS) and belonging to the myeloperoxidase (MPO) inhibitor class, which is a group known to have potential to treat a range of illnesses such as cardiovascular, inflammatory, and neurodegenerative diseases.

Sources report that Pfizer is planning to dump another applicant treating cardiovascular illnesses – monoglyceride lipase (MGLL) inhibitor PF-06818883. The inhibitor was being developed as a treatment for intracerebral hemorrhage, and glucagon receptor blocker PF-06293620 for type 2 diabetes was also discarded. Pfizer, in its second-quarter 2017 report said that it spent around US$ 3.49 billion on R&D during the first half of the year.

You may be interested

Metabolic Testing Market Key Trends, Demand, Growth, Size, Review, Share, Analysis to 2025
Business
Business

Metabolic Testing Market Key Trends, Demand, Growth, Size, Review, Share, Analysis to 2025

Albert R - October 19, 2018

The Metabolic Testing Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently released Metabolic Testing…

Soft Tissue Repair Market Have Rapid Growth During 2018-2026
Business
Business

Soft Tissue Repair Market Have Rapid Growth During 2018-2026

Albert R - October 19, 2018

The Soft Tissue Repair Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently released Soft…

Bone Marrow Transplant Market – Increasing Prevalence Of Cancers And Anemia All Over The World Is The Major Driver For The Growth
Healthcare
Healthcare

Bone Marrow Transplant Market – Increasing Prevalence Of Cancers And Anemia All Over The World Is The Major Driver For The Growth

Mohit Joshi - October 19, 2018

The Bone Marrow Transplant Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released Bone Marrow Transplant Market research report. The…

Most from this category